There is a pervasive lack of understanding about the definition of a developmental toxicant and the experimental design necessary to differentiate between maternal toxicants and those uniquely, i.e., selectively, hazardous to the conceptus. Thus, the acceptance of the adult-to-developmental (A/D) ratio and its ability to identify those compounds uniquely hazardous to the conceptus has been compromised, as has the extrapolation of hazard across species. The failure to establish a shared understanding is discussed, together with the role of an in vitro screen for determining the A/D ratio. The addition of an environmental exposure factor permitting the extrapolation of hazard assessment across species and the estimation of potential human developmental toxicity is detailed.
Daston GP, D'Amato RA. (1989) In vitro techniques in teratology. Toxicol Ind Health5:555–85.
2.
Daston GP, Rogers JM, Sabourin TD, Versteeg DJ (1989) Interspecies comparison of A/D ratios [Abstract]. Toxicologist9:32.
3.
Daston GP, Rogers JM, Versteeg DJ, Sabourin TD, Baines D, Marsh SS. (1991) Interspecies comparisons of A/D ratios: A/D ratios are not constant across species. Fundam Appl Toxicol17:696–722.
4.
Food and Drug Administration. (1966) Guidelines for Reproduction Studies for Safety Evaluation of Drugs for Human Use. Washington, D.C.: FDA.
5.
International Conference on Harmonization (ICH). (1993) International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use.
6.
Jensen M, Newman LM, Johnson EM. (1989) Problems in validation of in vitro developmental toxicity assays [Letter]. Fundam Appl Toxicol13:863–5.
7.
Johnson EM. (1980) Screening for teratogenic potential: are we asking the proper questions [Letter]?Teratology21:259.
8.
Johnson EM (1984) A prioritization and biological decision tree for developmental toxicity safety evaluations. J Am Coll Toxicol3:141–7.
9.
Johnson EM. (1987) A tier system for developmental toxicity evaluations based on considerations of exposure and effect relationships. Teratology35:405–27.
10.
Johnson EM. (1990) The effects of ribovirin on development and reproduction: a critical review of published and unpublished studies in experimental animals. J Am Coll Toxicol9:551–61.
11.
Johnson EM, Gabel BEG. (1982) Application of the hydra assay for rapid detection of developmental hazards. J Am Coll Toxicol1:57–71.
12.
Johnson EM, Gabel BEG. (1983) The role of an artificial embryo in detecting potential teratogenic hazards. Handbook Exp Pharmacol65:335–48.
13.
Johnson EM, Gorman RM, Gable BEG, George ME. (1982) The Hydra attenuata system for detection of teratogenic hazards. Teratogen Carcinogen Mutagen2:263–76.
14.
Johnson EM, Newman LM. (1990) Application of the hydra assay and its attendant concepts to considerations of maternal toxicity in developmental toxicity safety evaluation. Proceedings of the Society of Toxicology of Canada, November 28-29, 1989, Montreal, Quebec.
15.
Johnson EM, Newman LM (1992) Difficulties in identifying selective developmental toxicity [Letter]. Fundam Appl Toxicol18:635–9.
16.
Johnson EM, Newman LM, Fu LJ. (1989) Letter to the editor. Toxicol Appl Pharmacol99:173–6.
17.
Johnson EM, Newman LM, Gabel BEG, Boerner TE, Dansky LA. (1988) An analysis of the hydra assay's applicability and reliability as a developmental toxicity prescreen. J Am Coll Toxicol7:111–26.
18.
Karnofsky CA. (1965) Mechanisms of action of certain growth-inhibiting drugs. In: Wilson JG, War-kany J, eds. Teratology: Principles and Techniques. Chicago: University of Chicago Press, 185–213.
19.
Mayura K, Smith EE, Clement BA, Phillips TD. (1991) Evaluation of the developmental toxicity of chlorinated phenols utilizing Hydra attenuata and postimplantation rat embryos in culture. Toxicol Appl Pharmacol108:253–66.
20.
Polifka JE, Rutledge JC, Kimmel GL, Dellarco VV, Generoso WM. (1991) Skeletal deviations in mice offspring following zygotic exposure to ethylene oxide [Abstract]. Teratology43:444.
21.
Rogers JM. (1987) Comparison of maternal and fetal toxic dose responses in mammals. Teratogen Carcinogen Mutagen7:297–306.
22.
Rogers JM, Barbee B, Burkhead CM, Rushin EA, Kavlock RJ. (1988) The mouse teratogen dinocap has lower A/D ratios and is not teratogenic in the rat and hamster. Teratology37:553–9.
23.
Rutledge JC, Generoso WM. (1991) Congenital defects resulting from mutagen treatments of the mouse zygote [Abstract]. Teratology43:415.
24.
Schardein JL. (1987) Approaches to defining the relationship of maternal and developmental toxicity. Teratogen Carcinogen Mutagen7:255–71.
25.
Solomon HM, McLaughlin JE, Swenson RE, et al. (1993) Methyl methacrylate: inhalation developmental toxicity study in rats. Teratology48:115–25.
26.
U.S. Environmental Protection Agency. (1986) Guidelines for the health assessment of suspect developmental toxicants. Fed Regist51:34028–40.
